Click Here for 5% Off Your First Aladdin Purchase!

luvixasertib , CAS No.1610759-22-2, Inhibitor of TTK protein kinase

  • Moligand™
Item Number
L611619
Grouped product items
SKUSizeAvailabilityPrice Qty
L611619-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$240.90
L611619-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$930.90
View related series
TTK protein kinase Inhibitor

Basic Description

SynonymsCFI-402257|1610759-22-2|luvixasertib|HE97PTK3Q6|CFI402257|N-cyclopropyl-4-[7-[(3-hydroxy-3-methylcyclobutyl)methylamino]-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide|UNII-HE97PTK3Q6|CID 118086034|CHEMBL4442392|CHEMBL4469414|CFI 402257
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of TTK protein kinase

Associated Targets

TTK Tchem Dual specificity protein kinase TTK 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name N-cyclopropyl-4-[7-[(3-hydroxy-3-methylcyclobutyl)methylamino]-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide
INCHI InChI=1S/C28H30N6O3/c1-17-10-19(5-8-22(17)27(35)32-20-6-7-20)23-16-31-34-24(30-14-18-12-28(2,36)13-18)11-25(33-26(23)34)37-21-4-3-9-29-15-21/h3-5,8-11,15-16,18,20,30,36H,6-7,12-14H2,1-2H3,(H,32,35)
InChi Key PMQUGSPFUBGJCZ-UHFFFAOYSA-N
Canonical SMILES Cc1c(ccc(c1)c1c2nc(cc(n2nc1)NCC1CC(C1)(C)O)Oc1cnccc1)C(=O)NC1CC1
Isomeric SMILES CC1=C(C=CC(=C1)C2=C3N=C(C=C(N3N=C2)NCC4CC(C4)(C)O)OC5=CN=CC=C5)C(=O)NC6CC6
PubChem CID 118086034

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Liu Y, Laufer R, Patel NK, Ng G, Sampson PB, Li SW, Lang Y, Feher M, Brokx R, Beletskaya I et al..  (2016)  Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent..  ACS Med Chem Lett,  (7): (671-5).  [PMID:27437075]
2. Mason JM, Wei X, Fletcher GC, Kiarash R, Brokx R, Hodgson R, Beletskaya I, Bray MR, Mak TW.  (2017)  Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer..  Proc Natl Acad Sci U S A,  114  (12): (3127-3132).  [PMID:28270606]

Solution Calculators